Takeda

Hurricanes, droughts, and wildfires: How biopharma is girding for climate change
Stat
Fri, 02/15/19 - 10:29 am
climate change
natural disasters
tropical diseases
Takeda
AbbVie
Roche
Artificial Intelligence Gaining Ground in Drug Development
BioSpace
Mon, 02/11/19 - 10:00 am
CASP
machine learning
artificial intelligence
drug development
Merck
Takeda
Atomwise
Bayer
GSK
Google DeepMind
Recursion Pharmaceuticals
Takeda's Hemophilia A Drug: New Data and a $155 Million Patent Infringement Settlement
BioSpace
Wed, 02/6/19 - 11:17 am
Takeda
clinical trials
Adynovate
Baxalta
Bayer
patents
Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns over Drug Pricing
BioSpace
Fri, 02/1/19 - 11:27 am
earnings
Pfizer
Amgen
AbbVie
JNJ
Merck
Novo Nordisk
Takeda
Takeda's Phase III Dengue Vaccine Results Bring Them "One Step Closer" to Stopping Tropical Disease
BioSpace
Wed, 01/30/19 - 09:46 am
Takeda
vaccines
dengue
tropical diseases
Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more
CP Wire
Sun, 01/27/19 - 07:09 pm
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
Last week in biopharma-earnings reports, drug pricing, a new GENE CEO and more
Mon, 02/4/19 - 02:45 pm
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
Is the Smoldering NASH Market Ready to Burst Into Flames?
BioSpace
Tue, 01/22/19 - 11:52 am
NASH
Allergan
Regeneron
Alnylam
AstraZeneca
Merck
Takeda
Gilead Sciences
Bristol-Myers Squibb
Intercept Pharmaceuticals
Takeda mulling sale of emerging market drugs – report
Pharmaforum
Tue, 01/22/19 - 11:39 am
Takeda
Shire
M&A
emerging markets
Takeda’s Shire takeover could herald new era of pharma M&A
Pharmaforum
Wed, 01/9/19 - 09:18 am
M&A
Takeda
Shire
taxes
Pfizer
With mega merger season in full swing, Takeda officially swallows Shire
Endpoints
Tue, 01/8/19 - 07:09 pm
Takeda
Shire
M&A
Takeda to keep consumer business, looks outside Japan for selloffs instead: CEO
Fierce Pharma
Tue, 01/8/19 - 09:14 am
Takeda
Japan
consumer health
Christophe Weber
Takeda builds arsenal for immuno-oncology research, creates cell therapy group
Endpoints
Thu, 01/3/19 - 11:43 pm
Takeda
immuno-oncology
cell therapy
Shire
New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases
BioSpace
Fri, 12/28/18 - 01:30 pm
breast cancer
lung cancer
AstraZeneca
Tagrisso
Novartis
Gleevec
Tasigna
Bristol-Myers Squibb
Sprycel
Pfizer
Bosulif
Takeda
Iclusig
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
clinical trials
Takeda
Zinfandel Pharmaceuticals
pioglitazone
Alzheimer's disease
Boehringer Ingelheim
BI 409306
Merck
verubecestat
Celgene
MS
ozanimod
Incyte
ID01
melanoma
vTv Therapeutics
azeliragon
Roche
Tecentriq
Exelixis
colorectal cancer
JNJ
atabacestat
Sareptat Therapeutics
DMD
Exondys 51
Alkermes
ALKS-5461
clinical depression
Shire gears up to battle Allergan's Linzess with new constipation drug Motegrity
Fierce Pharma
Wed, 12/19/18 - 12:25 am
Takeda
Shire
Allergan
chronic idiopathic constipation
Motegrity
Eisai, Takeda and GARDP hunt for new antibiotics
Pharmaforum
Wed, 12/12/18 - 09:54 am
Eisai
Takeda
GARDP
antibiotics
R&D
Multiple Myeloma Research Foundation Bets on Adaptive Platform Clinical Trial Design
Xtalks
Mon, 12/10/18 - 07:07 pm
clinical trials
Multiple Myeloma
adaptive trial design
AbbVie
Celgene
Eli Lilly
Genentech
Janssen
Takeda
What do Martin Shkreli, Gilead and Takeda have in common? They all figure prominently in the new top-20 list of the world’s most expensive drugs
Endpoints
Wed, 12/5/18 - 11:32 am
Takeda
Gilead Sciences
Martin Shkreli
drug pricing
A last-ditch effort to derail Takeda’s $62B Shire buyout goes down in flames
Endpoints
Wed, 12/5/18 - 09:46 am
Takeda
Shire
M&A

Pages